Show simple item record

dc.contributor.authorKiconco, Prossy
dc.date.accessioned2021-03-29T09:16:16Z
dc.date.available2021-03-29T09:16:16Z
dc.date.issued2021-03
dc.identifier.citationKiconco, P. (2021). Pulmonary dimorphic fungal infections in HIV infected patients with NON-TB chronic cough at Mulago Hospital, Uganda (Unpublished master’s dissertation). Makerere University, Kampala, Uganda.en_US
dc.identifier.urihttp://hdl.handle.net/10570/8265
dc.descriptionA research dissertation submitted to the Directorate of Research and Graduate Training in partial fulfillment of the requirements for the award of a Master of Science in Immunology and Clinical Microbiology of Makerere University.en_US
dc.description.abstractIntroduction: Dimorphic fungi cause infection following inhalation of spores (conidia) into the pulmonary system. In the lower respiratory tract the conidia transform into the yeast phase which are engulfed by alveolar macrophages and may be destroyed without disease manifestation in healthy immune competent hosts. However, in some cases they may persist and cause fungal disease characterized by formation of granulomas in the infected tissues, which may mimic MTB. Dimorphic fungi of medical importance include Histoplasma capsulatum, Coccidioides immitis, Blastomyces dermatitidis, Paracoccidioides brasilience and Penecillium Marneffei. This study, therefore, set out to determine the role of dimorphic fungi role in pulmonary disease HIV/AIDS patients with chronic cough at Mulago Hospital Uganda. Methods: This was a cross-sectional study conducted from July 2020 – Feb-2021 at ISS Clinic Mulago and MBN Clinical Laboratories, One hundred and seventy five (175) HIV infected patients with chronic cough were consecutively selected. Upon Xpert/RIF test at ISS Clinic 21 participants were positive and 154 turned out negative. The 154 sputum samples that tested negative were then tested for dimorphic fungi at MBN Clinical Laboratories. Singleplex PCR was used where specific primers were used to detect a target sequency in the gene of particular dimorphic fungi, the resulting amplicons were electrophoresed on a 2% gel then visualized under UV light. Data analysis was then done using SPSS and STATA. Results: Blastomyces dermatitidis and Tarolomyces marneffei were detected in 16.4 % of the studied participants, with 9.1% and 7.1% respectively and 83.8% of the participant sample had no dimorphic fungi. Coccidiodes immitis, Paracoccidiodes brasiliensis and Histoplasma capsulatum were not detected in any of the participants. Conclusion: This study has shown that dimorphic fungi play a role in pulmonary disease among the HIV/AIDS with non- TB chronic in Uganda. We recommend patients of chronic cough who are TB negative to be investigated for dimorphic fungal infections as well.en_US
dc.description.sponsorshipCase Western Reserve University MITHU Grant Mapronano ACen_US
dc.language.isoenen_US
dc.publisherMakerere Universityen_US
dc.subjectNon-TBen_US
dc.subjectChronic coughen_US
dc.subjectHIV infected patientsen_US
dc.subjectPulmonary dimorphic fungal infectionsen_US
dc.titlePulmonary dimorphic fungal infections in HIV infected patients with NON-TB chronic cough at Mulago Hospital, Ugandaen_US
dc.typeThesisen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record